TCF4 and colorectal cancer: For example, >90% of colorectal cancer (CRC) patients show aberrant activation of the Wnt/β-catenin signalling pathway, resulting in sustained accumulation of β-catenin in the nucleus, and suggesting that transactivation of β-catenin-TCF4 target genes represents a primary initial event in CRC (ref. 11).